Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2012 December;64(4) > Minerva Urologica e Nefrologica 2012 December;64(4):233-43

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

  ADVANCES IN ONCOLOGICAL UROLOGY


Minerva Urologica e Nefrologica 2012 December;64(4):233-43

language: English

Optimizing prostate biopsy

Bostancı Y., Kazzazı A., Djavan B.

New York University School of Medicine, New York, NY, USA


PDF  


Prostate biopsy (PBx) techniques have changed significantly since the original Hodge’s scheme. Although the use of transrectal ultrasound (TRUS) guided (PBx) is considered the gold standard for the diagnosis of prostate cancer (Pca), the strategies for initial and repeat biopsies remain controversial. Even with the widespread application of extended prostate biopsy (ePBx) protocols, the false negative rate remains substantial and early PCa detection remains limited. Optimization of the PBx procedures reduce the likelihood of facing a “repeat biopsy dilemma”. The aim of this review is to provide an evidence-based update on current methods of PBx and discuss the strategies to optimise biopsy procedures.

top of page

Publication History

Cite this article as

Corresponding author e-mail

bob.djavan@nyumc.org